Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
93 Cards in this Set
- Front
- Back
What 2 types of drugs decrease venous pressure? |
diuretics and venodilators |
|
How do diuretics decrease venous pressure? |
by decreasing volume |
|
how do venodilators decrease venous pressure? |
increasing lumen |
|
How do diuretics increase the rate of urine flow? |
most by decreasing reabsorption of sodium (water follows Na+) |
|
What effect do diuretics have on GFR? |
most have no effect exception is osmotic diuretics |
|
major indication for diuretics? |
need to decrease extracellular fluid volume treatment of edema and effusions |
|
how do diuretics decrease extracellular fluid volume? |
decreasing body NaCl content -> water follows -> achieves new steady state |
|
where is Na+ reabsorbed in the nephron? |
proximal tubule thick ascending loop of Henle distal tubule |
|
what are the important targets of diuretics? |
NaK2Cl symport in thick ascending loop of Henle NaCl symport and mineralocorticoid receptor in distal tubule |
|
What is the traditional classification of diuretics? |
inconsistent: osmotic (MOA) loop diuretics (site of action) thiazides (chemistry) K+ sparing (effect on K+) |
|
Where do osmotic diuretics act? |
Loop of henle |
|
Examples of osmotic diuretics |
mannitol - used most often b/c more predictable glucose urea |
|
characteristics of osmotic diuretics |
freely filtered in glomerulus limited reabsorption relatively inert pharmacologically |
|
MOA of osmotic diuretics |
osmotic --> pulls water into vessels --> increase GFR decreased prox tubule reabsorption increased osmolality in thick ascending loop of Henle --> less Na reabsorped (decreased reabsorption in Loop of Henle) |
|
T/F Excretion of water is greater than electrolytes with osmotic diuretics |
true |
|
Theraputic uses for osmotics diuretics |
Anuric/Oliguric renal failure (emergency!) nephroprotection control intraocular pressure (acute glaucoma) decrease cerebral edema
|
|
Why are osmotic diuretics NOT used to treat heart failure? |
b/c osmotic diuretics draw fluid into the vessels which would create more work for a heart that cannot pump |
|
Toxicity and Adverse effects of Osmotic diuretics |
patients that cannot tolerate increased ECF volume (heart disease) hyponatremia (main electrolyte excreted) |
|
What is the MOA of "loop diuretics?" |
inhibitor of Na+-K+-2Cl- symport in thick ascending loop of henle --> blocks Na reabsorption and water stays with Na |
|
examples of inhibitors of Na+-K+-2Cl- symport |
Furosemide (Approved for vet use) Bumetamide Torsemide |
|
why are Na-K-2Cl symport inhibitors highly efficacious? |
b/c 25% of Na+ is reabsorbed in the loop of Henle where loop diuretics act distal segments have limited reabsorptive ability (salt transport virtually stops at this site) |
|
T/F Na-K-2Cl symport inhibitors excrete more water than electrolytes |
false water and electrolyte excretion is about equal |
|
theraputic uses for Na-K-2Cl symport inhibitors |
anuric/oliguric renal failure (emergency use) acute pulmonary edema edematous states ascites congestive heart failure |
|
Toxicity and adverse effects of Na-K-2Cl symport inhibitors |
diuretic related: dehydration and hypotension hyponatremia, hypochloremia, hypokalemia (metabolic alkalosis - classic for excessive loop diuretic use) |
|
Na-K-2Cl symport inhibitor drug interactions |
Aminoglycosides (compete for same transport increases nephrotoxicity) Digitalis (increases toxicity) Propanolol (increases plasma levels of propanolol) thiazides (synergistic effect on diuresis [increased urine]) |
|
Why is the use of sequential diuretics necessary? |
kidneys can upregulate resorption at distal nephron with continued diuretic (Na-K-2Cl symport inhibitor) use; thiazides (Na-Cl symport inhibitor) use is synergistic |
|
MOA of thiazides |
inhibit Na+-Cl- symport in the distal convoluted tubule |
|
why are thiazides less potent that loop diuretics? |
>90% of Na+ is reabsorbed before reaching the distal tubule max 5% of filtered load of Na+ is excreted in distal tubule |
|
What is a positive aspect of thiazides being less potent than loop diuretics (Na-K-2Cl symport inhibitors)? |
dehydration and hypokalemia are less pronounced |
|
examples of thiazides (Na-Cl symport inhibitors) |
chlorothiazide hydrochlorothiazide (used most) metolazone |
|
T/F inhibitors of Na-Cl symport excrete less water than electrolytes |
false Na-Cl symport inhibitors (thiazides) excrete approx equal amounts of water and electrolytes |
|
therapeutic uses of Na-Cl symport inhibitors (thiazides) |
edematous states congestive heart failure (second diuretic after loop diuretic [furosemide]) ascites (drug of choice in dogs b/c safer than loop diuretic [furosemide] for chronic use] calcium oxalate stones (adjuvant therapy) nephrogenic diabetes insipidus
|
|
toxicity and adverse effects of Na-Cl symport inhibitors |
diuretic related: dehydration and hypotension hyponatremia, hypochloremia, hypokalemia *less pronounced than with loop diuretics* |
|
What is the MOA of K sparing diuretics? |
aldosterone antagonists or mineralocorticoid receptor antagonists = competitive inhibitor more effect is seen if aldosterone is increased late distal tubule/collecting dut do not alter renal response to hydropenia
|
|
examples of mineralocorticoid receptor antagonists |
spironolactone eplerenone (expensive but more efficacious in humans) |
|
T/F mineralocorticoid receptor antagonists excrete equal amounts of water and electrolytes |
true |
|
theraputic uses of mineralocorticoid receptor antagonists |
second diuretic for edematous states, CHF*, ascites primary hyperaldosteronism proteinuria and hypertension *may prolong survival with CHF |
|
toxic and adverse effects of mineralocorticoid receptor antagonists |
hyperkalemia severe facial ulcerative dermatitis |
|
Nitrates are used for ___________________ |
venodilation - decrease venous pressure by increasing vessel lumen size |
|
MOA of nitrates |
nitrates form Nitric oxide in smooth muscle cells which stimulate relaxation |
|
Examples of venodilators and how administered |
nitroglycerin (transcutaneous - wear gloves!) isosorbide (oral) |
|
examples of mixed dilators and how administered |
nitroprusside (IV) |
|
why are nitrates used intermittently and primarily for emergencies? can anything else be given to help with this? |
tolerance develops in 24 hours (after depletion of sulfur?) ACE inhibitors and hydralazine can be used to decrease tolerance |
|
uses for venodilators? |
pulmonary edema from heart failure (systemic venodilation)
|
|
indications for use for Nitroglycerine? Isosorbide? |
Nitroglycerine - emergency heart failure Isosorbide - chronic use in refractory heart failure |
|
indication for use of nitroprusside? |
short-term management of severe, fulminant heart failure or hypertensive crisis (>200mmHg) |
|
why is nitroprusside IV use only? |
effect lasts only 5 minutes after drug is stopped; tolerance is not issue |
|
side effects and special consideration of nitroprusside? |
hypotension cyanogen toxicity with prolonged high dose IV use considerations - sensitive to light, heat, moisture |
|
examples of arterial vasodilators? |
hydralazine calcium-channel blockers alpha1-adrenoreceptor blockers |
|
What factors create vessel pressure? |
flow x resistance flow = cardiac output resistance = degree of vasocontriction |
|
Uses for arterial dilators? |
decrease blood pressure - systemic hypertension increase cardiac output - heart failure |
|
examples of calcium channel blockers |
amlodipine hydralazine prazosin |
|
MOA of amlodipine |
blocks calcium channels in systemic arteriolar smooth muscle (almost no effect on heart) |
|
clinical use of amlodipine |
hypertension - drug of choice in cats (most predictable of chronic use Ca-channel blockers) mitral regurgitation in dogs - rarely used |
|
Amlodipine PK oral bioavailibility: time to peak plasma conc: half life: protein binding: |
90% bioavailability 6 hrs to peak plasma conc 30h plasma half-life 95% protein bound |
|
adverse effects of amlodipine |
hypotension |
|
MOA of hydralazine |
direct vasodilator - likely increases prostacyclin concentration |
|
clinical uses of hydralazine |
hypertension - IV for hypertensive crisis, 3rd drug for refractory hypertension mitral regurgitation in dogs (refractory failure) |
|
hydralazine PK metabolism: oral absorption: time to peak plasma conc: effect in: stable for: lasts: |
dogs: first pass hepatic metabolism good oral absorption 3 hr to peak plasma conc effect begins in 20-60 min stable for 8-10 hrs lasts 12 hrs dose must be titrated |
|
adverse effects of hydralazine |
hypotension anorexia, vomitting reflex tachycardia |
|
Prazosin rarely used in _____, NOT used in _____ |
dogs, cats other safer drugs available |
|
clinical uses of Prazosin |
(mixed arterial and venodilator) arterial hypertension (refractory) urethral relaxation (other safer drugs available) |
|
What are ACE inhibitors and common uses? |
mixed arteriolar and venodilators used to prolong survival in heart failure and renal failure via neuroendocrine and local effects |
|
how does local angiotensinII contribute to progression of renal failure? |
1. increased glomerular pressure -> glom sclerosis and increased Angiotensin II 2. mesangial hypertrophy -> glom sclerosis and fibrosis 3. increased TGF-B -> mesangial hypertrophy, glom sclerosis and fibrosis 4. increased NF-kappaB -> inflammation |
|
What are ACE inhibitors? |
special vasodilators not very potent weak hemodynamic effects |
|
MOA of ACE inhibitors |
angiotensin converting enzyme inhibition (systemic and local) |
|
examples of ACE inhibitors |
Enalapril Benazepril Ramipril Lisinopril (Captopril) |
|
clinical uses of ACE inhibitors |
systemic hypertension first drug for patients with proteinuria, renal failure d/t nephroprotection second drug for other patients heart failure - vasodilator of choice, neuroendocrine modulation prolongs survival renal failure - proteinuria, increased survival |
|
Adverse effects of ACE inhibitors |
hypotension (rare) anorexia and vomiting renal disease (failure?) in patients that are volume depleted (in heart disease, kidney interprets body as volume depleted --> nephrtoxic) |
|
how do ACE inhibitors work differently in cats than dogs? |
won't reduce hypertension in cats in 20% of dogs, BP reduced by 20 mmHg does not resolve proteinuria in cats but does prevent progression |
|
what's the difference between Enalapril and Benazepril? |
different manufacturers that funded studies |
|
What do urinary incontinence drugs target? |
2 sphincters (1 striated, 1 smooth muscle) if weak -> increased contraction if too strong -> decrease contraction |
|
What is hypotonic urethra? Signalment?
|
sphincter incompetence adult female dogs
|
|
What classes of drugs increase urethral tone? |
alpha-adrenergic agonists reproductive hormones |
|
Examples of alpha-adrenergic agonists |
phenylpropanolamine (PPA) phenylephrine |
|
MOA of Phenylpropanolamine |
direct stimulation of alpha adrenergic receptors |
|
how efficacious if phenylpropanolamine? phenylephrine? |
PPA: excellent results in >85% of cases can be used in males and females should be dosed TID so if giving BID and not effective, try TID Phenylephrine: effect is less predictable also BID-TID |
|
adverse effects of alpha-adrenergic agonists |
anorexia weight loss hyperexcitability tachycardia hypertension - common, measure BP |
|
Reproductive hormones used for hypotonic urethra? |
Diethylstilbestrol (DES) Testosterone |
|
MOA of DES? |
sensitization and up-regulation of alpha receptors |
|
efficacy of DES? administration? |
success rate of 60-70% can be used in females, also males but not seen starting dose and maintenance dose- use as least often as efficacious |
|
adverse effects of DES? |
alopecia estrus signs bone marrow suppression (reversible but may become irreversible) |
|
Testosterone use for hypotonic ureter |
can be used in males but rarely needed can only be given IM has side effects |
|
What is hypertonic urethra? |
sphincter contraction is too strong all the time or contracted at inappropriate times |
|
what class of drugs are used for hypertonic urethra? examples? |
alpha adrenergic antagonists Phenoxybenzamine Diazepam
|
|
MOA of phenoxybenzamine |
irreversibly inactivates alpha receptors - decreases smooth muscle tone |
|
which species is phenoxybenzamine less effective? |
cats - less predictable b/c striated muscle predominates in feline urethra |
|
adverse effects of phenoxybenzamine |
hypotension reflex tachycardia GI upset |
|
MOA of diazepam? administration? |
decreases striated muscle tone give 15-330 minutes prior to micturtion (take potty) higher doses lead to sedation |
|
adverse effects of diazepam |
sedation weakness paradoxical excitement hepatotoxicity (cats) |
|
causes of hypotonic bladder |
neurologic diseases overdistension of bladder |
|
general category of drugs used to treat hypotonic bladder? examples? |
cholinergic agents bethanechol |
|
efficacy of Bethanechol? adverse effects? |
unreliable full effect in 1-2 days, voiding w/in 2 hrs may increase urethral tone (start alpha blocker like phenoxybenzimine first) SLUD (salivation, defecation) b/c activating PS tone GI - abdominal cramps, vomiting, diarrhea
|